Investors & Media

Press Releases

Press Releases

Press Releases

  • May 09, 2023

    Anokion Announces New Clinical Data from the Phase 1 ACeD Trial Supporting KAN-101 as a Potential Disease-modifying Treatment for Celiac Disease

    Read More